Urachal carcinoma with liver, lung, and brain metastases: benefit of a new combination chemotherapy (bevacizumab, 5-fluorouracil, irinotecan) – case report
Clinical Oncology in Adolescents and Young Adults · 2011
DOI: 10.2147/coaya.s18841 ↗Kurz gefasst
Fallbericht in der Zeitschrift Clinical Oncology in Adolescents and Young Adults, 2011. Verfasst von Filip Geurs und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Geurs, F., Demetter, P., Geurs, F., & Deloecker, R. (2011). Urachal carcinoma with liver, lung, and brain metastases: benefit of a new combination chemotherapy (bevacizumab, 5-fluorouracil, irinotecan) – case report. Clinical Oncology in Adolescents and Young Adults. https://doi.org/10.2147/coaya.s18841
Vancouver
Geurs F, Demetter P, Geurs F, Deloecker R. Urachal carcinoma with liver, lung, and brain metastases: benefit of a new combination chemotherapy (bevacizumab, 5-fluorouracil, irinotecan) – case report. Clinical Oncology in Adolescents and Young Adults. 2011. doi:10.2147/coaya.s18841
BibTeX
@article{Geurs2011,
author = {Geurs, Filip and Demetter, Pieter and Geurs, Filip and Deloecker, R.},
title = {Urachal carcinoma with liver, lung, and brain metastases: benefit of a new combination chemotherapy (bevacizumab, 5-fluorouracil, irinotecan) – case report},
journal = {Clinical Oncology in Adolescents and Young Adults},
year = {2011},
doi = {10.2147/coaya.s18841}
}
EUVIMED